| Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects IE Mba, EI Nweze World Journal of Microbiology and Biotechnology 37, 1-30, 2021 | 243 | 2021 |
| Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms HC Sharndama, IE Mba Brazilian Journal of Microbiology 53 (1), 33-50, 2022 | 209 | 2022 |
| Mechanism of Candida pathogenesis: revisiting the vital drivers IE Mba, EI Nweze European Journal of Clinical Microbiology & Infectious Diseases 39 (10 …, 2020 | 148 | 2020 |
| Focus: antimicrobial resistance: antimicrobial peptides therapy: an emerging alternative for treating drug-resistant bacteria IE Mba, EI Nweze The Yale journal of biology and medicine 95 (4), 445, 2022 | 94 | 2022 |
| The use of nanoparticles as alternative therapeutic agents against Candida infections: an up-to-date overview and future perspectives IE Mba, EI Nweze World Journal of Microbiology and Biotechnology 36 (11), 163, 2020 | 52 | 2020 |
| The resurgence of phage-based therapy in the era of increasing antibiotic resistance: from research progress to challenges and prospects NJ Anyaegbunam, CC Anekpo, ZKG Anyaegbunam, Y Doowuese, ... Microbiological research 264, 127155, 2022 | 50 | 2022 |
| Genome plasticity in Candida albicans: A cutting-edge strategy for evolution, adaptation, and survival IE Mba, EI Nweze, EA Eze, ZKG Anyaegbunam Infection, Genetics and Evolution 99, 105256, 2022 | 36 | 2022 |
| Vaccine development for bacterial pathogens: Advances, challenges and prospects IE Mba, HC Sharndama, ZKG Anyaegbunam, CC Anekpo, BC Amadi, ... Tropical Medicine & International Health 28 (4), 275-299, 2023 | 25 | 2023 |
| Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update IE Mba, HC Sharndama, GO Osondu-Chuka, OP Okeke Infectious Diseases 53 (8), 559-580, 2021 | 14 | 2021 |
| Application of nanotechnology in the treatment of infectious diseases: an overview IE Mba, EI Nweze Nanotechnology for infectious diseases, 25-51, 2022 | 11 | 2022 |
| Antimicrobial resistance: revisiting the mechanisms of resistance IE Mba, OP Okeke, HC Sharndama, GO Osondu-Chuka, J Ukuomadu, ... Access Microbiology 4 (5), po0577, 2022 | 5 | 2022 |
| Antimicrobial resistance containment in Africa: Moving beyond surveillance ZKG Anyaegbunam, IE Mba, Y Doowuese, NJ Anyaegbunam, T Mba, ... Biosafety and Health 6 (01), 50-58, 2024 | 3 | 2024 |
| Antifungal resistance profile and enzymatic activity of Candida species recovered from human and animal samples IE Mba, EI Nweze Bio-Research 17 (1), 1044A-1055A, 2019 | 2 | 2019 |
| Revisiting the smart metallic nanomaterials: advances in nanotechnology-based antimicrobials NJ Anyaegbunam, IE Mba, AO Ige, TE Ogunrinola, OK Emenike, ... World Journal of Microbiology and Biotechnology 40 (3), 102, 2024 | 1 | 2024 |
| Biofilm Formation in Candida Species MI Elibe, NE Innocent Recent Advances in Human Fungal Diseases: Progress and Prospects, 239-259, 2024 | | 2024 |
| Identification and characterization of bacteria isolated from patients with cancer at Enugu State Teaching Hospital Parklane, Enugu, Nigeria OP Okeke, MEU Dibua, EA Ocholi, V Nwoko, IE Mba, JC Ukomadu Bio-Research 20 (3), 1659-1666, 2022 | | 2022 |
| Biosynthesis of Silver Nanoparticles from Aspergillus flavus and Aqueous Extract of Gnetum Marie E. U. Dibua, Joseph Ukomadu, Emmanuel S. Okeke, Onome Ejeromedoghene ... Tropical Journal of Natural Product Research 5 (11), 2005-2010, 2021 | | 2021 |
| Genetic relatedness between human and animal Candida albicans isolates recovered from Southeastern Nigeria using random amplification of polymorphic DNA-PCR EI Nweze, IE Mba Journal of Basic Pharmacology and Toxicology 4 (1), 16-22, 2020 | | 2020 |
